APA (7th ed.) Citation

Gafita, A., Fendler, W. P., Hui, W., Sandhu, S., Weber, M., Esfandiari, R., . . . Hofman, M. S. (2020). Efficacy and safety of 177Lu-labeled prostate-specific membrane antigen radionuclide treatment in patients with diffuse bone marrow involvement: A multicenter retrospective study. European urology, 78(2), . https://doi.org/10.1016/j.eururo.2020.05.004

Chicago Style (17th ed.) Citation

Gafita, Andrei, et al. "Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study." European Urology 78, no. 2 (2020). https://doi.org/10.1016/j.eururo.2020.05.004.

MLA (9th ed.) Citation

Gafita, Andrei, et al. "Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study." European Urology, vol. 78, no. 2, 2020, https://doi.org/10.1016/j.eururo.2020.05.004.